Results 31 to 40 of about 319,815 (308)

Risk Factors for Development of Stroke in Patients With Continuous-Flow Left Ventricular Assist Device Support as Destination Therapy [PDF]

Texas Heart Institute Journal
Background: Continuous-flow left ventricular assist devices (LVADs) are increasingly used as destination therapy. Although postimplantation stroke rates have been described in the context of bridge-to-transplant or mixed cohorts, stroke development is ...
Ioana B. Florea, MD, MPHS, Nadia H. Bakir, MD, Meghan O. Kelly, MD, Joel D. Schilling, MD, PhD, Gregory A. Ewald, MD, Akinobu Itoh, MD, PhD, Marc R. Moon, MD, Spencer J. Melby, MD, Ralph J. Damiano, Jr, MD, Kunal D. Kotkar, MD, Muhammad F. Masood, MD   +10 more
doaj   +1 more source

Effect of Vascular Lumen Reduction on the Performance and Energy Consumption of an Innovative Implantable LVAD

Applied Sciences, 2023
This paper presents the results of a study on the effect of vascular lumen reduction on the performance of an innovative implantable LVAD (left ventricular assist device).
Ryszard Jasinski, Krzysztof Tesch, Leszek Dabrowski, Jan Rogowski   +3 more
doaj   +1 more source

Innovative Implantable Left Ventricular Assist Device—Performance under Various Resistances and Operating Frequency Conditions

Applied Sciences, 2023
This paper presents the operation of an innovative left ventricular assist device under various resistances and operating frequencies. The operating principle of the device is based on pulsatile blood flow, which is forced by a suction–discharge device ...
Ryszard Jasinski, Krzysztof Tesch, Leszek Dabrowski, Jan Rogowski   +3 more
doaj   +1 more source

Impact of prolonged microaxial flow pump support on outcomes in heart transplantation: A single-center experienceCentral MessagePerspective

JTCVS Open
Objective: To evaluate whether patients receiving prolonged Impella 5.5 support (greater than 30 days) as a bridge to heart transplantation experience comparable outcomes with those receiving shorter-term support (up to 30 days).
Muhammad F. Masood, MD, Mehran Rahimi, MD, Ryan Mikami, BS, Mary Kate Freyaldenhoven, BS, R.J. Waken, PhD, Irene Fischer, MPH, Maxwell Braasch, MD, Maya Weerasooriya, BS, Jackson Haynes, BS, Nguyen Huyen Tran Nguyen, BS, Kunal Kotkar, MD, Ralph J. Damiano, Jr., MD, Tsuyoshi Kaneko, MD, Amit Pawale, MD   +13 more
doaj   +1 more source

Assessment of Coagulation and Hemostasis Biomarkers in a Subset of Patients With Chronic Cardiovascular Disease

Clinical and Applied Thrombosis/Hemostasis, 2021
Measurement of a single marker of coagulation may not provide a complete picture of hemostasis activation and fibrinolysis in patients with chronic cardiovascular diseases. We assessed retrospective orders of a panel which included prothrombin fragment 1.
Maureen J. Miller MD, MPH, Cheryl L. Maier MD, PhD, Alexander Duncan MD, Jeannette Guarner MD   +3 more
doaj   +1 more source

Experimental Investigation of the Performance of an Innovative Implantable Left Ventricular Assist Device—Proof of Concept

Applied Sciences, 2023
This paper presents the results of experimental performance of an innovative left ventricular assist device working on a specially designed test stand. The introduced invention is mainly applied for supporting the heart in patients with end-stage heart ...
Krzysztof Tesch, Ryszard Jasinski, Leszek Dabrowski, Jan Rogowski   +3 more
doaj   +1 more source

Cutting the Cord: A Case of Late Presenting Driveline Infection [PDF]

, 2020
Ventricular assist device (VAD) related infection, specifically driveline infection, is a common complication after VAD implantation. A 45-year old patient with a delayed skin infection at the site of the original driveline nearly one year after VAD ...
Eyadiel, Lauren, Laughey, Brian, Pisani, Barbara   +2 more
core   +1 more source

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]

, 2017
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J., Bruckner, Brian A., Chuang, Joyce, Estep, Jerry D., Farrar, David J., Haas, Donald C., Horstmanshof, Douglas A., Kasirajan, Vigneshwar, Lee, Sangjin, Long, James W., Milano, Carmelo A., Rogers, Joseph G., Selzman, Craig H., Shah, Keyur B., Starling, Randall C., Stehlik, Josef   +15 more
core   +2 more sources

Ethical challenges with the left ventricular assist device as a destination therapy

Philosophy, Ethics, and Humanities in Medicine, 2008
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y, Verheijde Joseph L, Rizzieri Aaron G, McGregor Joan L   +3 more
doaj   +1 more source

Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices [PDF]

, 2020
Background: Left ventricular assist device (LVAD) therapy has been proven to relieve heart failure symptoms and improve survival, but is not devoid of bleeding and/or thrombotic complications.
Cook, Aaron, Kuan, William, McCann, Justin McCann, Parli, Sara, Schadler, Aric, Sieg, Adam, Zacholski, Kyle   +6 more
core   +1 more source